Roivant Sciences

How a 32-Year-Old CEO Got a Team of Pharma Vets to Join His Radical Approach to Making Drugs
Health

Industry Analyst

By
September 21, 2017
Forbes Under 30 Summit
Health

Why SoftBank Made a Record-Breaking $1.1 Billion Bet on This Biotech Firm

By
August 9, 2017
Forbes Under 30 Summit
Health

This 31-Year-Old CEO Is Snapping Up Drug Industry Veterans Left and Right

By
July 10, 2017
Forbes Under 30 Summit
Health

This 31-Year-Old Just Launched His 5th Biotech Company With a Boost From Merck

By
June 6, 2017

Most Popular